clopidogrel has been researched along with Brain Ischemia in 292 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (3.77) | 18.2507 |
2000's | 68 (23.29) | 29.6817 |
2010's | 168 (57.53) | 24.3611 |
2020's | 45 (15.41) | 2.80 |
Authors | Studies |
---|---|
Du, Y; He, L; Liu, Q; Wang, H; Wang, J; Xu, J; Xu, X | 1 |
Atkins, JL; Bowden, J; Delgado, J; Ferrucci, L; Fullalove, H; Kuchel, GA; Kuo, CL; Masoli, JAH; Melzer, D; Pilling, LC; Türkmen, D | 1 |
Huang, Z; Yang, Y; Zhang, X | 1 |
Harmsze, AM; Hilkens, PHE; Minderhoud, C; Otten, LS; van den Broek, MPH | 1 |
Jin, A; Laskowitz, DT; Li, H; Li, J; Lin, J; Meng, X; Pan, Y; Wang, Y; Wangqin, R; Xian, Y | 1 |
Ip, A; Lau, KK; Ng, AK; Ng, PY; Siu, CW | 1 |
Liu, S; Shah, J; Yu, W | 1 |
Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I | 1 |
Bonaffini, N; Cupini, LM | 1 |
Appleton, JP; Bath, PM; Dawson, J; England, TJ; Eveson, D; Krishnan, K; Law, ZK; Mavilakandy, A; Minhas, JS; Mistri, A; Robinson, TG; Sprigg, N | 1 |
Amarenco, P; Bath, PM; Chen, W; Gao, Y; Han, S; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, C; Wang, T; Wang, Y; Yang, Y; Zhao, X | 1 |
Bae, JW; Bong, JM; Chun, KJ; Han, JK; Hwang, D; Kang, HJ; Kang, J; Kim, HS; Kim, SY; Koo, BK; Lee, BK; Lee, KS; Lee, NH; Lim, HS; Lim, YH; Park, K; Park, KH; Park, KW; Rha, SW; Rhew, JY; Shin, WY; Yang, HM | 1 |
Hwang, HY; Kang, Y; Kim, JS; Sohn, SH | 1 |
Bar, M; Cernik, D; Cihlar, F; Herzig, R; Husty, J; Jura, R; Klail, T; Kocher, M; Kočí, L; Kovacova, I; Kovar, M; Mikulik, R; Nevšímalová, M; Raupach, J; Rocek, M; Sanak, D; Sedova, P; Sevcik, P; Skoloudik, D; Sramek, M; Tomek, A; Vaclavik, D; Vanicek, J; Vaško, P; Vinklarek, JF | 1 |
Deng, L; Gong, T; He, L; Lin, Y; Luo, Y; Xia, Y; Zhang, H; Zhang, Z | 1 |
Appleton, JP; Bath, PM; Christensen, H; Dineen, RA; England, TJ; James, M; Krishnan, K; Montgomery, AA; Ranta, A; Robinson, TG; Sprigg, N; Woodhouse, LJ | 1 |
Hankey, GJ | 2 |
Chan, L; Chen, YC; Hsu, CY; Hu, CJ; Lin, CL; Muo, CH; Vidyanti, AN; Wu, D | 1 |
Alexopoulos, D; Altman, RB; Aradi, D; Backman, JD; Bergmeijer, TO; Bliden, KP; Campo, G; Chang, K; Cleator, JH; Déry, JP; Dridi, NP; Fernandez-Cadenas, I; Fontana, P; Gawaz, M; Geisler, T; Gensini, GF; Giusti, B; Gong, L; Gurbel, PA; Hochholzer, W; Holmvang, L; Kim, EY; Kim, HS; Klein, TE; Kubo, M; Lee, MTM; Lewis, JP; Marcucci, R; Mitchell, BD; Montaner, J; Pakyz, RE; Reny, JL; Ritchie, MD; Roden, DM; Ryan, K; Schaeffeler, E; Schwab, M; Shin, JG; Shuldiner, AR; Siller-Matula, JM; Ten Berg, JM; Trenk, D; Valgimigli, M; Wen, MS; Whaley, RM; Winter, S | 1 |
Jung, JM; Kim, BJ; Kim, SM; Kwon, SU; Lee, JS | 1 |
Khong, T; Kimpton, J | 1 |
Chen, X; Fang, W; Fei, Y; Hou, K; Khadankhuu, B; Li, F; Li, Y; Xu, D | 1 |
Del Aguila, M; Girotra, S; Hu, B; Ince, B; Jeng, JS; Kutluk, K; Liu, L; Lou, M; Min Han, J; Paciaroni, M; Paek, D; Parfenov, V; Wong, KSL; Zamani, B | 1 |
Cheng, Z; Cui, Y; Gong, Y; Guo, D; Lei, H; Lin, F; Shao, X; Wang, L; Wang, Z; Yang, D; Zhang, Q; Zhang, S; Zhao, G | 1 |
Doshi, R; Kumar, A; Shariff, M | 1 |
Chen, S; Liu, G; Yang, S | 1 |
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Nanto, S; Nishikawa, M; Ogawa, A; Toyoda, K | 1 |
Fukuda, K; Heidenreich, PA; Ikemura, N; Kohsaka, S; Numasawa, Y; Sandhu, AT; Sawano, M; Shiraishi, Y; Shoji, S; Suzuki, M; Ueno, K | 1 |
Dong, J; Sundararajan, S; Wang, F | 1 |
Lin, J; Yi, X; Zhang, Y; Zhou, J; Zhou, Q | 1 |
Cui, YM; Hu, K; Jiang, J; Liu, ZY; Ma, LY; Mu, GY; Wang, Z; Xiang, Q; Xie, QF; Zhang, HX; Zhang, Z | 1 |
Bush, S; Chan, J; Churilov, L; Coulthard, A; Dowling, R; Hocking, J; Kwan, P; Mahady, K; Mitchell, P; Sreedharan, S; Todaro, M; Yan, B | 1 |
Choi, SG; Kang, JW; Kim, DW; Kim, SK; Shin, HJ; Song, HJ; Yi, YY | 1 |
Cheng, Y; Ge, W; Han, Z; Huang, L; Jin, J; Luo, C; Shao, T; Wang, Z; Xu, Y; Yang, D | 1 |
Ahn, SH; Han, SW; Jung, YH; Kim, J; Kim, YD; Lee, HS; Lee, JY; Lee, KY; Song, TJ | 1 |
Ang, YK; De Silva, DA; Narasimhalu, K; Tan, DSY; Tan, KB | 1 |
Appleton, JP; Bath, PM; Dovlatova, N; Heptinstall, S; May, J; Richardson, C; Sprigg, N | 1 |
Feng, Q; Fu, J; Jin, X; Shan, B; Shen, R; Yu, Z; Zhou, H; Zhu, H | 1 |
Ji, RJ; Lin, YJ; Yuan, HW | 1 |
Jia, Q; Jia, W; Wang, Y; Zhang, Y; Zhao, X | 1 |
Kargiotis, O; Tsivgoulis, G | 1 |
Hsu, YH; Ong, CT; Tsai, CF; Wong, YS | 1 |
Fang, W; Gou, X; Hou, K; Li, F; Li, Y; Lv, N; Xu, D | 1 |
Chan, BP; Leow, AS; Sharma, VK; Sia, CH; Tan, BY; Tan, CH; Wu, AG; Yeo, LL | 1 |
Cho, B; Choi, HC; Kim, SJ; Kwon, OD; Lee, EJ | 1 |
Dhaliwal, S; Dowlatshahi, D; Hutton, B; Lun, R; Roy, DC; Shorr, R; Zitikyte, G | 1 |
de Havenon, A; Easton, JD; Furie, KL; Henninger, N; Johnston, SC; Kim, AS; Kvernland, A; Mac Grory, B; Rostanski, S; Yaghi, S | 1 |
Bath, PM; Dong, Q; Jing, J; Johnston, C; Li, H; Li, Z; Meng, X; Pan, Y; Wang, A; Wang, Y; Xie, X; Xu, A; Zhao, X | 1 |
Chen, J; Gao, P; Han, M; Jia, W; Kuang, J; Peng, C; Starcevich, K; Tu, J; Wang, J; Wu, Y; Yi, Y; Yin, S; Zhang, X | 1 |
Long, Z; Wa, D; Zhu, P | 1 |
Chen, W; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, D; Wang, Y; Zhao, X | 1 |
Fiolaki, A; Giannopoulos, S; Katsanos, AH; Kosmidou, M; Kyritsis, AP; Moschonas, IC; Papadaki, S; Tselepis, AD | 1 |
Anstrom, KJ; Bagai, A; Cohen, DJ; Effron, MB; Henry, TD; McCoy, LA; Peterson, ED; Schulte, PJ; Stone, GW; Wang, TY; Zettler, ME | 1 |
Bigliardi, G; Dell'Acqua, ML; Ferraro, D; Lelli, N; Mimmi, S; Nichelli, P; Pentore, R; Picchetto, L; Rosafio, F; Trenti, T; Vandelli, L; Zini, A | 1 |
Cao, Y; Dong, K; Liu, L; Rao, Z; Wang, A; Wang, F; Wang, Y; Zhao, X; Zheng, H | 1 |
Elisaf, M; Manios, E; Milionis, H; Ntaios, G; Papavasileiou, V; Spengos, K; Vemmos, K | 1 |
Ikeda-Sakai, Y; Nakase, T; Sasaki, M | 1 |
Chen, XL; Dai, QL; Han, YF; Liu, WH; Liu, XF; Ma, MM; Xiong, YY; Xu, GL; Yin, Q; Zhang, RL; Zhu, WS | 1 |
Cai, X; Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, D; Wang, Y; Wei, T; Zhao, X | 1 |
Allan, L; Broderick, J; Brown, RD; Chalouhi, N; Chimowitz, M; Derdeyn, CP; Hasan, D; Jabbour, P; Leira, EC; Nagahama, Y; Nakagawa, D; Starke, RM; Torner, JC; Zanaty, M | 1 |
Chen, J; Ding, N; Li, G; Peng, L; Shao, Y; Wang, Y; Xu, Z; Zhang, C | 1 |
Appleton, JP; Bath, PM; Beridze, M; Christensen, H; Dineen, RA; Duley, L; England, TJ; Flaherty, K; Havard, D; Heptinstall, S; James, M; Krishnan, K; Markus, HS; Montgomery, AA; Pocock, SJ; Randall, M; Ranta, A; Robinson, TG; Scutt, P; Sprigg, N; Venables, GS; Woodhouse, LJ | 1 |
Bonetti, B; Bovi, P; Cappellari, M; Forlivesi, S; Toni, D; Turcato, G; Zivelonghi, C | 1 |
Christiansen, CF; Grove, EL; Henderson, VW; Horváth-Puhó, E; Schmidt, M; Sørensen, HT; Würtz, M | 1 |
Bilker, WB; Brensinger, CM; Grosser, T; Hennessy, S; Kasner, SE; Leonard, CE; Li, X; Nam, YH | 1 |
Chen, Z; Dai, Z; Han, Y; Hao, Y; Li, W; Liu, R; Liu, X; Qiu, Z; Sun, W; Wang, H; Xiong, Y; Xu, G; Yin, Q; Zi, W | 1 |
Barsan, W; Conwit, RA; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY | 1 |
Chai, Z; Han, Z; Huang, R; Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
Cho, KH; Choi, KH; Kim, JT; Lee, JS; Park, MS; Saver, JL | 1 |
Fyfe, I | 1 |
Ben-Yehuda, O; Brodie, BR; Cox, DA; Dangas, GD; Duffy, PL; Farhan, S; Généreux, P; Giustino, G; Gurbel, P; Henry, TD; Kirtane, AJ; Maehara, A; Mazzaferri, EL; McAndrew, T; Mehran, R; Metzger, DC; Neumann, FJ; Redfors, B; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B | 1 |
Barlas, RS; Bettencourt-Silva, JH; Bowles, KM; Clark, AB; Ford, I; Loke, YK; Mamas, MA; Metcalf, AK; Myint, PK; Potter, JF | 1 |
Jiang, WJ; Li, C; Liu, AF; Qiu, H; Wang, K; Wu, Z; Zhang, Y; Zhou, J | 1 |
Chai, Z; Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
Jeong, HY; Kang, MK; Kim, TJ; Ko, SB; Lee, CH; Lee, JS; Mo, H; Nam, KW; Yoon, BW | 1 |
Chiba, T; Fujimoto, K; Fujiwara, S; Kobayashi, M; Kubo, Y; Ogasawara, K; Setta, K; Shimada, Y; Terasaki, K; Tsutsui, S; Yoshida, J; Yoshida, K | 1 |
Chaparro, E; Fedorova, E; Griffin, A; Hauck, EF; Holmes, C; Manson, RJ | 1 |
Abdalla, A; Ahmed, S; Al Qasmi, M; Bachuwa, G; Bhatt, DL; Chahine, A; Hassan, M; Haykal, T; Kheiri, B; Osman, M; Swaid, B | 1 |
Darkwah Oppong, M; Deuschl, C; Forsting, M; Gembruch, O; Jabbarli, R; Kaier, K; Kleinschnitz, C; Köhrmann, M; Mönninghoff, C; Pierscianek, D; Sure, U | 1 |
Foroutan, F; Guyatt, G; Hao, Q; O'Donnell, M; Siemieniuk, RA; Tampi, M | 1 |
Agoritsas, T; Booth, B; Fisch, L; Fobuzi, AC; Fraiz, A; Gorthi, SP; Guyatt, G; Hao, Q; Heen, AF; Horton, E; Jusufovic, M; Katragunta, N; Lytvyn, L; Muller, J; O'Donnell, M; Prasad, K; Rochwerg, B; Siemieniuk, J; Siemieniuk, R; Vandvik, PO | 1 |
de Leeuw, FE; Koopman, A; Meijer, F | 1 |
Cui, Y; Gong, Y; Jiang, J; Wang, Z; Xiang, Q; Xie, Q | 1 |
Abe, K; Ikeda, Y; Kitagawa, K; Kitazono, T; Matsumoto, M; Minematsu, K; Nagao, T; Nagata, I; Nanto, S; Nishikawa, M; Ogawa, A; Tanahashi, N; Toyoda, K; Uchiyama, S; Yamagami, H | 1 |
Dong, N; Liang, L; Liu, ZZ; Lu, BC; Shi, XJ | 1 |
Henriksson, R; Mooe, T; Söderström, L; Ulvenstam, A | 1 |
Hammad, T; Kaluski, E; Khan, SU; Meyer, MA; Nasir, F; Rahman, H | 1 |
Hanada, H; Inoue, R; Mitsutake, T; Morinaga, Y; Nii, K; Sakamoto, K | 1 |
Bae, HJ; Cha, JK; Cho, YJ; Choi, JC; Choi, KH; Gorelick, PB; Han, MK; Hong, JH; Hong, KS; Kang, K; Kim, BJ; Kim, D; Kim, DE; Kim, DH; Kim, JG; Kim, JT; Kim, WJ; Kwon, JH; Lee, BC; Lee, J; Lee, JS; Lee, KB; Lee, SJ; Nah, HW; Oh, MS; Park, JM; Park, TH; Ryu, WS; Shin, DI; Sohn, SI; Yu, KH | 1 |
Laskowitz, DT; Li, H; Liu, L; Meng, X; Miao, Z; Wang, X; Wang, Y; Xie, X; Zhao, X | 1 |
Uchino, K | 1 |
Abumiya, T; Amano, S; Fukuma, K; Fukunaga, R; Furui, E; Hamasaki, T; Hyun, B; Ihara, M; Ito, Y; Kitagawa, K; Manabe, Y; Miyata, S; Miyata, T; Nagatsuka, K; Nakagawara, J; Tanaka, T; Toyoda, K; Uchiyama, S; Yamagami, H; Yamamoto, H; Yamamoto, Y; Yasaka, M | 1 |
Barsan, W; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY; Tillman, H | 1 |
Björklund, F; Henriksson, R; Mooe, T | 1 |
Easton, JD; Hoshino, H; Houkin, K; Isobe, M; Kimura, K; Minematsu, K; Naritomi, H; Okada, Y; Origasa, H; Sakai, N; Tanaka, K; Toyoda, K; Uchiyama, S; Yamaguchi, K; Yamaguchi, T | 1 |
Kitaeva, EY; Mickhalevich, IM; Mirzaev, KB; Shprakh, VV; Sychev, DA | 1 |
Al Sultan, AA; Almekhlafi, MA; Assis, Z; Goyal, M; Kashani, N; Podlasek, A | 1 |
Dowie, J; Kaltoft, MK | 1 |
Hong, JM; Joo, IS; Lee, JS; Lim, YA; Shin, DH | 1 |
Aurigemma, C; D'Ambrosio, A; Di Sciascio, G; Giardina, A; Leporace, M; Macrì, M; Melfi, R; Patti, G; Ricottini, E; Sedati, P; Tomai, F | 1 |
Bauer, D; Berger, PB; Charnigo, RJ; Dunn, SP; Steinhubl, SR; Topol, EJ | 1 |
Albright, KC; Beasley, TM; Boehme, AK; Jones, EM; Leung, LY; Martin-Schild, S; Pletsch, GR; Shah, KR; Siegler, JE; Tarsia, J | 1 |
Deguchi, I; Fukuoka, T; Hayashi, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Ohe, Y; Tanahashi, N | 1 |
Baxter, MS; Dumont, TM; Eller, JL; Hopkins, LN; Levy, EI; Mokin, M; Natarajan, SK; Siddiqui, AH; Snyder, KV; Sorkin, GC; Wach, MM | 1 |
Beynon, C; Sakowitz, OW; Unterberg, AW | 1 |
Han, YL; Kang, J; Li, Y; Liang, ZY; Yan, CH; Zhang, XL | 1 |
Ha, SY; Kim, HC; Kim, SE; Mun, CW; Park, J; Park, KM; Shin, KJ | 1 |
Hokari, M; Kacimi, R; Ma, H; McManus, A; Tang, XN; Webster, CM; Yenari, MA | 1 |
Chełstowski, K; Clark, J; Jastrzębska, M; Nowacki, P; Siennicka, A; Wódecka, A | 1 |
Hong, KS; Lee, M; Ovbiagele, B; Rao, NM; Saver, JL; Wu, YL | 1 |
Kichikawa, K; Nakagawa, H; Nakagawa, I; Nakase, H; Nishimura, F; Park, HS; Wada, T; Yamada, S | 1 |
Angiolillo, DJ; Bauer, D; Bhatt, DL; Ferreiro, JL; Ueno, M | 1 |
Bekbosynov, AZh | 1 |
Castilla-Guerra, L; Fernandez-Moreno, Mdel C; Jimenez-Gonzalo, F; Navas-Alcantara, MS | 1 |
Deguchi, I; Fukuoka, T; Hayashi, T; Horiuchi, Y; Kato, Y; Maruyama, H; Nagamine, Y; Ohe, Y; Sano, H; Tanahashi, N | 1 |
Aoki, S; Hosomi, N; Ito, H; Kataoka, S; Kohriyama, T; Matsumoto, M; Mihara, C; Mukai, T; Nezu, T; Noda, K; Nomura, E; Ohtsuki, T; Ota, T; Takamatsu, K; Takeda, I; Torii, T; Yamada, A; Yokoyama, T | 1 |
Chen, CY; Huang, YB; Lai, WT; Lee, CT; Lee, KT | 1 |
Amarenco, P; Cohen, AA; Davis, S; Donnan, GA; Heiss, WD; Jones, EF; Kaste, M; Laouénan, C; Macleod, M; Young, D | 1 |
Barlinn, K; Bodechtel, U; Gahn, G; Gehrisch, S; Grählert, X; Heinke, D; Kepplinger, J; Puetz, V; Reichmann, H; Schwanebeck, U; Siepmann, T | 1 |
Bai, J; Chen, J; Chen, P; Eikelboom, JW; Gong, X; Kong, D; Li, C; Liu, J; Meng, H; Xu, L; Yang, Z; Zou, F | 1 |
Akioka, N; Hayakawa, Y; Kashiwazaki, D; Kuroda, S; Kuwayama, N | 1 |
Ikeda, Y; Isshiki, T; Kimura, T; Kitagawa, K; Miyazaki, S; Nakamura, M; Nanto, S; Nishikawa, M; Ogawa, H; Saito, S; Takayama, M; Yokoi, H | 1 |
Huang, L; Lai, X; Li, W; Xiong, Z; Xu, A; Zhang, S | 1 |
Chang, KC; Lee, HC; Lee, JD; Lee, M; Lee, TH; Ovbiagele, B; Rao, NM; Saver, JL; Wang, HH; Wu, CY; Wu, YL | 1 |
Hoshino, H; Kimura, K; Minematsu, K; Naritomi, H; Origasa, H; Toyoda, K; Uchiyama, S; Yamaguchi, T | 1 |
Han, RF; Li, X; Liu, J; Qiu, LN; Sun, Y; Wang, L; Xia, XS | 1 |
Chun, S; Jeong, TD; Kang, DW; Kim, HJ; Kim, SM; Kwon, SU; Lee, W; Min, WK | 1 |
Bath, PM; Dineen, R; Pocock, S; Robson, K; Sprigg, N; Woodhouse, LJ | 1 |
Bilker, WB; Brensinger, CM; Flockhart, DA; Freeman, CP; Hennessy, S; Kasner, SE; Kimmel, SE; Leonard, CE | 1 |
Han, RF; Li, X; Liu, J; Qiu, LN; Wang, L; Xia, XS | 1 |
Gurbel, PA; Liu, F; Tantry, US | 1 |
Yang, J; Yang, ZH; Zhang, YD; Zhao, HD; Zhao, YX; Zhou, JS; Zou, JJ | 1 |
Blann, AD; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F | 1 |
Asai, T; Haraguchi, K; Izumi, T; Matsubara, N; Miyachi, S; Ota, K; Shintai, K; Tajima, H; Wakabayashi, T; Yamanouchi, T | 1 |
Cheng, X; Dong, Q; Su, Y | 1 |
Dong, Q; Guan, YT; Han, Y; Jiang, JM; Li, SX; Liu, X; Luo, Z; Lv, HH; Wu, S; Xu, JF; Yang, XL; Zhang, Y; Zheng, Y; Zhu, DS | 1 |
Budde, U; Dittmer, R; Eckert, B; Flechtenmacher, N; Kämmerer, F; Michels, P; Röther, J | 1 |
Chan, J; Churilov, L; Dowling, RJ; Kwan, P; Lin, M; Mitchell, PJ; Ramdave, S; Todaro, M; Yan, B; Zhu, WS | 1 |
Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP | 1 |
An, LX; Dong, Q; Guan, YT; Han, Y; Jiang, JM; Li, L; Li, SX; Liu, X; Luo, Z; Lv, HH; Wu, S; Xu, JF; Yang, XL; Zheng, SL | 1 |
Carlson, N; Christiansen, CB; Gerds, TA; Gislason, G; Jørgensen, ME; Kristensen, SL; Numé, AK; Olesen, JB; Pallisgaard, J; Torp-Pedersen, C | 1 |
Ambrus, JL; Chichelli, T; Ching, M; Janicke, D; Munschauer, F; Sawyer, R; Sternberg, D; Sternberg, Z; Yu, J | 1 |
Fang, L; Huang, H; Lin, M; Wang, N; Yang, Z; Zhao, Y | 1 |
Iijima, K; Imazeki, R; Kohara, S; Mizuma, A; Ohnuki, Y; Shimizu, M; Takizawa, S; Uesugi, T | 1 |
Ahn, SH; Han, SW; Kim, YJ; Kim, YN; Lee, KY; Oh, SH; Seo, WK; Yu, S | 1 |
Angelopoulou, SM; Bouziana, SD; Giampatzis, V; Hatzitolios, AI; Kostaki, S; Papadopoulou, M; Savopoulos, C; Spanou, M; Tsopozidi, M; Tziomalos, K | 1 |
Coughlan, CA; Gutkin, M; Kinsella, J; Lonergan, R; McCabe, DJ; Murphy, SJ; Tobin, O | 1 |
Grajek, S; Komosa, A; Kowal, J; Lesiak, M; Mączyński, M; Michalak, M; Mularek-Kubzdela, T; Siller-Matula, JM; Siniawski, A; Wiśniewski, S | 1 |
Armstrong, PW; Chin, CT; Corbalán, R; Fox, KA; Magnus Ohman, E; Neely, B; Prabhakaran, D; Roe, MT; White, HD; Winters, KJ | 1 |
Carrera, C; Cullell, N; Fernandez-Cadenas, I; Fontana, P; Gallego-Fabrega, C; Krupinski, J; Martí-Fàbregas, J; Montaner, J; Muiño, E; Pera, J; Pezzini, A; Reny, JL; Segura, T; Serrano-Heras, G; Slowik, A | 1 |
Cheng, SY; Gong, ZL; Li, J; Liu, Y; Shuai, J; Wang, L; Xiong, XY; Yang, QW; Zhao, T; Zhou, Y; Zhu, WY | 1 |
Davis, K; Dietrich, E | 1 |
Chen, Y; Fu, C; Lin, J; Liu, P; Wang, C; Yi, X | 1 |
Dillinger, JG; Drouet, L; Henry, P; Saeed, A; Sideris, G; Silberman, SM; Sollier, CB; Spagnoli, V; Voicu, S | 1 |
Bae, HJ; Cha, JK; Chang, DI; Cho, KH; Cho, YJ; Choi, JC; Hong, KS; Kang, DW; Kim, DE; Kim, EG; Kim, GM; Kim, HY; Kwon, SU; Lee, J; Lee, KB; Lee, SH; Lee, SJ; Lee, YS; Park, JM; Park, KY; Rha, JH; Sohn, CH; Sohn, SI; Yoon, BW; Yu, KH | 1 |
Chen, C; Deng, QQ; Fu, JH; Huang, YN; Markus, H; Ratanakorn, D; Tang, J; Wong, KS; Zhao, H | 1 |
Cheng, W; Chi, L; Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
He, Y; Jing, J; Li, H; Pan, Y; Wang, Y | 1 |
Cheng, W; Han, Z; Lin, J; Wang, C; Yi, X; Zhou, Q | 1 |
Cai, H; Liu, X; Wang, Y; Zhang, Z; Zhou, G | 1 |
Appleton, JP; Bath, PM; Beridze, M; Christensen, H; Dineen, RA; Duley, L; England, TJ; Flaherty, K; Heptinstall, S; James, M; Krishnan, K; Markus, HS; Pocock, S; Ranta, A; Robinson, TG; Scutt, P; Sprigg, N; Venables, GS; Woodhouse, LJ | 1 |
Bakoyiannis, C; Georgopoulos, S; Karaolanis, G; Moris, D | 1 |
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Sawlani, NN; Steg, PG; Stone, GW; White, HD | 1 |
Cao, Q; Dong, K; Feng, W; Hou, C; Huang, X; Ji, X; Ovbiagele, B; Song, H; Wang, M; Wang, Y; Zhang, Q | 1 |
Chao, PW; Chen, HT; Chen, YT; Hsu, CY; Kuo, SC; Ou, SM; Shih, CJ | 1 |
Jing, J; Johnston, SC; Li, H; Liu, L; Meng, X; Pan, Y; Wang, D; Wang, Y; Zhao, X | 1 |
Li, W; Li, XG; Ma, N; Miao, ZR; Sun, SS; Wang, YJ; Xu, Z; Yang, X; Zhao, ZG | 1 |
Belvís, R; Kulisevsky, J; Pagonabarraga, J; Santamaría, A | 1 |
Sztriha, LK; Vécsei, L | 1 |
Albers, GW; Amarenco, P; Easton, JD; Sacco, RL; Teal, P | 1 |
Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S | 1 |
Saseen, JJ; Vande Griend, JP | 1 |
Abdelmoula, MM; Divani, AA; Hussein, HM; Qureshi, AI; Suri, MF | 1 |
Cha, JK; Jeon, HW; Kang, MJ | 1 |
Minnerup, J; Schäbitz, WR | 1 |
Hart, RG | 1 |
Hegge, KA | 1 |
Faxon, DP; Freedman, JE | 1 |
Balucani, C; Cordonnier, C; Leys, D | 1 |
Biller, J | 1 |
Dzialowski, I; Gahn, G; Hermann, A; Koch, R | 1 |
Beckman, JA | 1 |
Hopkins, LN; Ionita, CC; Levy, EI; Natarajan, SK; Siddiqui, AH; Snyder, KV | 1 |
Bal Dit Sollier, C; Bergmann, JF; Bousser, MG; Crassard, I; Drouet, L; Simoneau, G | 1 |
Gomez, CR; Qureshi, AI | 1 |
Hashimoto, A; Ito, H; Matsumoto, Y; Miyakoda, G; Yao, H | 1 |
Arnao, V; Di Raimondo, D; Di Sciacca, R; La Placa, S; Licata, G; Miceli, S; Milio, G; Pinto, A; Tuttolomondo, A | 1 |
Meyer, D | 1 |
Atar, D; Booze, C; Cherala, G; Kuliczkowski, W; Serebruany, V; Surigin, S; Williams, C | 1 |
Ahmed, N; Diedler, J; Ford, GA; Lees, KR; Luijckx, GJ; Overgaard, K; Ringleb, P; Soinne, L; Sykora, M; Uyttenboogaart, M; Wahlgren, N | 1 |
Böhm, M; Dichgans, M; Diener, HC; Endres, M; Grond, M; Hacke, W; Hoppe, UC; Kirchhof, P; Laufs, U; Meinertz, T; Ringelstein, EB; Rosenkranz, S; Röther, J | 1 |
Bath, PM; Cotton, D; Diener, HC; Estol, C; Martin, RH; Palesch, Y; Roberts, R; Sacco, R; Yusuf, S | 1 |
Burke, JP; Henk, H; Sander, S; Shah, H; Zarotsky, V | 1 |
Bracco, S; Cerase, A; Galluzzi, P; Mandalà, M; Nuti, D; Rufa, A; Venturi, C | 1 |
Mayer, TE; Reinhöfer, M; Weise, J; Witte, OW | 1 |
Ellrodt, G; Fonarow, GC; Frankel, MR; Hernandez, AF; Labresh, KA; Liang, L; Menon, BK; Schwamm, LH; Smith, EE | 1 |
Bae, JH; Bae, JW; Chae, IH; Cho, MC; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Kwon, TG; Lee, HY; Lee, SP; Park, KW; Rha, SW; Suh, JW | 1 |
Abildstrøm, SZ; Andersen, SS; Clausen, MT; Fog-Petersen, ML; Folke, F; Gadsbøll, N; Gislason, GH; Hansen, ML; Køber, L; Poulsen, HE; Raunsø, J; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
Abduljalil, AM; Bergdall, VK; Christoforidis, GA; Khanna, S; Knopp, MV; Koch, RM; Kontzialis, MS; Mohammad, Y; Rink, C; Roy, S; Sen, CK; Slivka, AP | 1 |
Kario, K; Sakata, T | 1 |
Bhatt, DL; Brennan, D; Easton, JD; Fox, KA; Hacke, W; Hankey, GJ; Johnston, SC; Mak, KH; Mas, JL; Topol, EJ | 1 |
Alexandrov, M; Chibisova, Y; Fedorov, A; Gall, C; Sabel, BA; Szymaszek, A | 1 |
Deguchi, I; Dembo, T; Fukuoka, T; Furuya, D; Horiuchi, Y; Kato, Y; Maruyama, H; Nagoya, H; Takeda, H; Tanahashi, N | 1 |
Bae, JH; Bae, JW; Chae, IH; Cho, MC; Cho, YS; Choi, DJ; Kang, HJ; Kim, HS; Koo, BK; Kwon, TG; Lee, HY; Lee, SP; Park, KW; Rha, SW; Suh, JW; Youn, TJ | 1 |
Kamal, AK; Khan, M | 1 |
Easton, JD | 1 |
Gaillard, R; Mir, O | 1 |
Gonzenbach, RR; Luft, A; Russmann, S; Taegtmeyer, AB | 1 |
Byrne, RA; Kastrati, A; Sibbing, D | 1 |
Arnold, M; Findling, O; Fischer, U; Galimanis, A; Geister, L; Jung, S; Mattle, HP; Meier, B; Mono, ML; Nedeltchev, K; Praz, F; Wahl, A; Windecker, S; Wolff, S | 1 |
Buschmann, IR; Busjahn, A; Duelsner, A; Gatzke, N; Glaser, J; Hillmeister, P; Lee, EJ; Lehmann, K; Li, M; Meyborg, H; Nagorka, S; Persson, AB; Stawowy, P; Urban, D | 1 |
Bae, JH; Bae, JW; Chae, IH; Cho, MC; Kim, HS; Lee, SP; Park, KW; Rha, SW; Suh, JW | 1 |
Bagust, A; Blundell, M; Boland, A; Dickson, R; Dundar, Y; Fisher, M; Greenhalgh, J; Martin Saborido, C; Oyee, J; Proudlove, C | 1 |
Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S | 1 |
Endres, HG; Krogias, C; Meves, SH; Neubauer, H; Overbeck, U | 1 |
Chichelli, T; Ching, M; Farooq, O; Janicke, D; Li, F; Mehta, B; Munschauer, FE; Radovic, V; Sawyer, RN; Sternberg, Z | 1 |
Blatchford, J; Demchuk, AM; Diehl, A; Diener, HC; Forsting, M; Gizewski, ER; Hermansson, K; Möller-Hartmann, C; Sacco, RL; Saver, JL; Wanke, I; Warach, S; Weber, R; Weimar, C | 1 |
Acelajado, MC; Oparil, S | 1 |
Algra, A; Bath, MW; Bath, PM; Chen, C; Dengler, R; Diener, HC; Geeganage, CM; Markus, HS; Topol, EJ | 1 |
Passlick, B; Wiesemann, S | 1 |
Ahmed, N; Egido, JA; Ford, GA; Lees, KR; Mazya, M; Mikulik, R; Toni, D; Wahlgren, N | 1 |
Agarwal, S; Hachamovitch, R; Menon, V | 1 |
Abrigo, J; Ahuja, AT; Leung, TW; Ng, N; Siu, DY; Soo, YO; Wong, LK; Yu, S | 1 |
Becker, RC; Husted, S; James, SK; Keltai, M; Khurmi, NS; Lopes, RD; Lopez-Sendon, JL; Mahaffey, KW; Maya, J; Morais, J; Nicolau, JC; Pais, P; Raev, D; Stevens, SR; Storey, RF | 1 |
Bakdash, S; Bhatt, DL; Depta, JP; Fowler, J; Katzan, I; Kottke-Marchant, K; Novak, E | 1 |
Koch, S; Reyes-Iglesias, Y; Rose, DZ; Yavagal, DR | 1 |
Abel, TJ; Chalouhi, N; Hasan, DM; Jabbour, PM; Kung, DK; Rossen, JD; Thomas, J; Wassef, SN | 1 |
Collins, R; Coughlan, T; Cox, D; Kinsella, JA; McCabe, DJ; Murphy, RP; O'Neill, D; Tobin, WO | 1 |
Connolly, SJ; Coppens, M; Dorian, P; Eikelboom, JW; Hart, RG; Lip, GY; Shestakovska, O; Yusuf, S | 1 |
Kamal, AK; Wadiwala, MF | 1 |
Kanorsky, SG; Shevelev, VI | 1 |
Michel, P; Milionis, H | 1 |
Anderson, DC; Thomson, RM | 1 |
Buggle, F; Grau, AJ; Lichy, C; Reiners, S; Ruf, A | 1 |
Bae, HR; Cha, JK; Cheon, SM; Jeong, MH; Lee, KM; Lim, YJ; Park, KW | 1 |
Uchiyama, S; Yamazaki, M | 1 |
Bhatt, DL; Hacke, W; Hirsch, AT; Ringleb, PA; Topol, EJ | 2 |
Bae, HR; Cha, JK; Ho, JM; Jo, WS; Kim, JW; Shin, HC | 1 |
Haerten, K; Krabbe, C; Raiber, M | 1 |
Boddy, AW; Brandt, T; Buggle, F; Dukovic, DA; Grau, AJ; Hacke, W; Lichy, C | 1 |
Jüttler, E; Meyding-Lamadé, UK; Schellinger, PD; Schwark, C | 1 |
Pongrácz, E | 1 |
Lewis, SC; Warlow, CP | 1 |
Shamalov, NA; Skvortsova, VI | 1 |
Moussouttas, M; Papamitsakis, N | 1 |
Eriksson, P | 1 |
Bath, P; Fletcher, S; Fox, S; Heptinstal, S; Leonardi-Bee, J; May, J; Weaver, C; Willmot, M; Zhao, L | 1 |
Ringleb, PA; Schellinger, PD; Schwaninger, M; Schwark, C | 1 |
Eikelboom, JW; Hankey, GJ | 1 |
Amighi, J; Brunner, M; Exner, M; Felber, K; Funk, M; Mannhalter, C; Minar, E; Mlekusch, W; Müller, M; Sabeti, S; Schillinger, M; Ziegler, S | 1 |
Hart, RG; Pearce, LA; Tonarelli, SB | 1 |
Hong, KW; Lee, JH; Lee, WS; Park, SY | 1 |
Akhmetov, VV; Alekseeva, GS; Gutsaliuk, AG; Lemenev, VL; Skvortsova, VI; Stakhovskaia, LV | 1 |
Hacke, W | 1 |
Alberts, MJ; Bhatt, DL; Hanley, DF; Malinin, AI; Pokov, AN; Serebruany, VL; Ziai, W | 1 |
Berger, PB; Bhatt, DL; Black, HR; Boden, WE; Booth, J; Cacoub, P; Cohen, EA; Creager, MA; Easton, JD; Flather, MD; Fox, KA; Hacke, W; Haffner, SM; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Mas, JL; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Topol, EJ; Weber, MA | 1 |
Szapáry, L | 1 |
Fisher, M | 1 |
Bath, PM; Gray, L; Heptinstall, S; Leonardi-Bee, J; Weaver, CS; Zhao, L | 1 |
Allen, A; deVeber, G; Hune, S; MacGregor, D; Rafay, MF; Soman, T | 1 |
Ahmed, S; Ferguson, R; Hershey, LA; Kirmani, JF; Pande, RU; Qazi, KJ; Qureshi, AI; Safdar, A; Sayed, MA | 1 |
Daniel, WG; Eigenthaler, M; Garlichs, CD; Hentschel, B; Hild, E; Kobsar, A; Lohmann, T; Siegemund, A; Spilcke-Liss, E; Stumpf, C; Wallaschofski, H | 1 |
Fehér, G; Horváth, B; Késmárky, G; Koltai, K; Tóth, K | 1 |
Galor, A; Hoffman, GS; Lee, MS; Smith, SD | 1 |
Al-Bahrani, A; Bakhiet, M; Shaath, H; Taha, S | 1 |
Bene, J; Feher, G; Havasi, V; Horvath, B; Komlosi, K; Melegh, B; Papp, E; Szapary, L; Talian, G; Toth, K | 1 |
Bego, G; Carita, P; Gabriel, S; Hakimi, Z; Hankey, GJ; Spiesser, J | 1 |
Emre, U; Rantanen, K; Tatlisumak, T | 1 |
Diener, HC | 1 |
Husted, SE; Overgaard, K; Poulsen, TS | 1 |
Dorsch, MP; Reaume, KT; Regal, RE | 1 |
Adams, RJ; Albers, G; Alberts, MJ; Benavente, O; Furie, K; Goldstein, LB; Gorelick, P; Halperin, J; Harbaugh, R; Johnston, SC; Katzan, I; Kelly-Hayes, M; Kenton, EJ; Marks, M; Sacco, RL; Schwamm, LH | 1 |
Brace, LD; Cursio, J; Grossi, E; Helgason, CM; Pandey, D; Valika, A | 1 |
Brandslund, I; Buck, TC; Christensen, C; Jørgensen, LG; Nielsen, AA; Veien, KT | 1 |
Edovina, LN; Luk'ianov, IuV; Parusova, EV; Sokurenko, GIu | 1 |
Jamieson, DG; Skliut, M | 1 |
Adams, HP; Bendixen, BH | 1 |
Violi, F | 1 |
Bahadori, B; Toplak, H; Wascher, TC | 1 |
Davie, AP; Love, MP | 1 |
Hacke, W; Orberk, E; Schellinger, PD | 1 |
Algra, A; Koudstaal, PJ; van Gijn, J | 1 |
Ferguson, JJ; Gonzalez, ER; Kannel, WB; Olin, JW; Raps, EC | 1 |
Boysen, G | 1 |
Chesebro, JH; Comerota, A; Hartmann, JR; Massin, EK; Raps, E; Wolf, PA; Zusman, RM | 1 |
Caro, JJ; Migliaccio-Walle, K | 1 |
Dunbabin, DW; Hankey, GJ; Sudlow, CL | 1 |
Jackson, G | 1 |
56 review(s) available for clopidogrel and Brain Ischemia
Article | Year |
---|---|
Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis.
Topics: Aspirin; Brain Ischemia; Cerebral Infarction; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Quality of Life; Secondary Prevention; Stroke; Systematic Reviews as Topic | 2021 |
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke; Ticagrelor | 2022 |
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Physicians; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke | 2022 |
Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke | 2019 |
Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Time Factors; Treatment Outcome | 2019 |
Use of Dual Antiplatelet Therapy Following Ischemic Stroke.
Topics: Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke | 2020 |
Predicting ischaemic events using platelet reactivity in patients receiving clopidogrel: Indirect meta-comparison among VerifyNow, light transmission aggregometry and thromboelastography.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Brain Ischemia; Clopidogrel; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Risk Factors | 2020 |
The 2020 breakthroughs in early secondary prevention: dual antiplatelet therapy versus single antiplatelet therapy.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Early Medical Intervention; Hemorrhage; History, 21st Century; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke | 2021 |
Cilostazol for secondary stroke prevention: systematic review and meta-analysis.
Topics: Brain Ischemia; Cilostazol; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2021 |
Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack-Protocol for a systematic review and network meta-analysis.
Topics: Aspirin; Bayes Theorem; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Network Meta-Analysis; Platelet Aggregation Inhibitors; Ticagrelor | 2021 |
Comparative efficacy and safety of antiplatelet agents in cerebral ischemic disease: A network meta-analysis.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Network Meta-Analysis; Odds Ratio; Platelet Aggregation Inhibitors; Survival Analysis; Treatment Outcome | 2019 |
High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis.
Topics: Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2017 |
Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Time Factors; Treatment Outcome | 2019 |
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Ischemic Attack, Transient; Mortality; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Severity of Illness Index; Stroke | 2018 |
Predictive Value of Methods Measuring Platelet Activation for Ischemic Events in Patients Receiving Clopidogrel: A Systematic Review and Meta-analysis.
Topics: Brain Ischemia; Clopidogrel; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Predictive Value of Tests | 2018 |
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or Transient Ischemic Attack.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Secondary Prevention; Stroke | 2019 |
Outcome of intracranial flow diversion according to the antiplatelet regimen used: a systematic review and meta-analysis.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Male; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Self Expandable Metallic Stents; Ticagrelor; Treatment Outcome | 2020 |
Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.
Topics: Aged; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2013 |
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine | 2013 |
Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.
Topics: Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Tetrazoles; Thrombosis; Ticlopidine | 2015 |
P2Y12 receptor inhibitors for secondary prevention of ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Hemorrhage; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Secondary Prevention; Stroke; Ticlopidine | 2015 |
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Humans; Mortality; Numbers Needed To Treat; Observational Studies as Topic; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Stroke; Thiazoles; Thrombophilia; Ticlopidine; Vitamin K | 2015 |
Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications.
Topics: Antiplatyhelmintic Agents; Aspirin; Brain Ischemia; Clopidogrel; Evidence-Based Medicine; Humans; Stroke; Ticlopidine | 2015 |
Clopidogrel in secondary ischemic stroke prevention.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thrombolytic Therapy; Ticlopidine; Treatment Outcome | 2008 |
Combination antiplatelet agents for secondary prevention of ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2008 |
Multifunctional actions of approved and candidate stroke drugs.
Topics: Albumins; Animals; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Cytidine Diphosphate Choline; Dipyridamole; Erythropoietin; Granulocyte Colony-Stimulating Factor; Humans; Hypolipidemic Agents; Neuroprotective Agents; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2009 |
What's new in stroke? The top 10 studies of 2006-2008. Part I.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2008 |
Antiplatelet agents for prevention of recurrent ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine | 2009 |
Antiplatelet drugs for ischemic stroke prevention.
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Confounding Factors, Epidemiologic; Decision Making; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Follow-Up Studies; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Platelet Aggregation Inhibitors; Research Design; Secondary Prevention; Ticlopidine | 2009 |
Antithrombotic therapies in cerebrovascular disease: what should we use as secondary prevention in patients with carotid artery disease?
Topics: Anticoagulants; Aspirin; Brain Ischemia; Carotid Stenosis; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Patient Selection; Risk Assessment; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
Antiplatelet treatment in ischemic stroke treatment.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2009 |
Antiplatelets and stroke outcomes: state of the science.
Topics: Arachidonic Acid; Aspirin; Aspirin, Dipyridamole Drug Combination; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Combinations; Evidence-Based Practice; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Risk Reduction Behavior; Safety; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2009 |
Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).
Topics: Adenosine; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Cilostazol; Clinical Trials as Topic; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Fibrinolytic Agents; Foramen Ovale, Patent; Genotype; Humans; Ischemic Attack, Transient; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
Role of platelet function testing in clinical practice: current concepts and future perspectives.
Topics: Acute Coronary Syndrome; Biotransformation; Brain Ischemia; Clopidogrel; Drug Monitoring; Drug Resistance; Humans; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk; Ticlopidine | 2011 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Humans; Models, Economic; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Ticlopidine | 2011 |
Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Databases, Factual; Dipyridamole; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Stroke; Survival Rate; Ticlopidine | 2012 |
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Brain Ischemia; Clopidogrel; Female; Humans; Incidence; Male; Oligosaccharides; Primary Prevention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin | 2012 |
Acute ischemic cerebrovascular events on antiplatelet therapy: what is the optimal prevention strategy?
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Life Style; Medication Adherence; Patient Education as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Ticlopidine | 2013 |
Aspirin and clopidogrel for prevention of ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2013 |
[The value of platelet inhibitors in the secondary prophylaxis of stroke -- a review].
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome | 2004 |
Combination antiplatelet agents in ischemic cerebrovascular disease.
Topics: Aspirin; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2005 |
Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Health Care Costs; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2005 |
Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Assessment; Secondary Prevention; Stroke; Thromboembolism; Ticlopidine | 2005 |
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2005 |
[Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recurrence; Stroke; Ticlopidine; Warfarin | 2005 |
Results of the management of atherothrombosis with clopidogrel in high-risk patients trial: implications for the neurologist.
Topics: Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Thrombosis; Ticlopidine; Treatment Outcome | 2006 |
Antithrombotic treatment in the prevention of ischemic stroke.
Topics: Anticoagulants; Blood Coagulation; Brain Ischemia; Clopidogrel; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thrombin; Ticlopidine; Treatment Outcome | 2007 |
The PRoFESS trial: future impact on secondary stroke prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Forecasting; Humans; Internationality; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome; Vasodilator Agents | 2007 |
Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Brain Ischemia; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Evidence-Based Medicine; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2008 |
Update on antiplatelet agents, including MATCH, CHARISMA, and ESPRIT.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2008 |
Ticlopidine or clopidogrel as alternatives to aspirin in prevention of ischemic stroke.
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1996 |
[Antithrombotic therapy after cerebral ischemia].
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Heparinoids; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 1997 |
[Secondary prevention following cerebral ischemia: is monotherapy with acetylsalicylic acid still first choice?].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine | 1998 |
Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.
Topics: Algorithms; Arteriosclerosis; Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Critical Pathways; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Ticlopidine | 1999 |
Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine | 2000 |
65 trial(s) available for clopidogrel and Brain Ischemia
Article | Year |
---|---|
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA.
Topics: Brain Ischemia; Cerebral Infarction; Cholesterol, LDL; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Stroke | 2022 |
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclero
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Atorvastatin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Ischemic Stroke; Middle Aged; Platelet Aggregation Inhibitors; Stroke | 2023 |
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial.
Topics: Acute Coronary Syndrome; Brain Ischemia; Clopidogrel; Diabetes Mellitus; Hemorrhage; Humans; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke | 2023 |
Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia.
Topics: Acute Disease; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Quality of Life; Stroke | 2023 |
Safety and Efficacy of Prasugrel in Elderly/Low Body Weight Japanese Patients with Ischemic Stroke: Randomized PRASTRO-II.
Topics: Age Factors; Aged; Aged, 80 and over; Asian People; Body Weight; Brain Ischemia; Clopidogrel; Double-Blind Method; Female; Health Status; Hemorrhage; Humans; Incidence; Japan; Male; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Recurrence; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2020 |
A comparison of three platelet function tests in ischemic stroke patients with antiplatelet therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Thrombelastography | 2020 |
Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Carotid Stenosis; Clopidogrel; Dual Anti-Platelet Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Stroke | 2021 |
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke | 2021 |
Personalized antiplatelet therapy based on clopidogrel/aspirin resistance tests in acute ischemic stroke and transient ischemic attack: Study protocol of a multi-center, single-blinded and randomized controlled trial.
Topics: Aftercare; Aspirin; Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Multicenter Studies as Topic; Patient Discharge; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke | 2021 |
Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: Time course analysis of CHANCE.
Topics: Aspirin; Brain Ischemia; China; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Blood Glucose; Brain Ischemia; Clopidogrel; Double-Blind Method; Female; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Male; Middle Aged; Risk Factors; Serum Albumin; Stroke; Ticlopidine | 2017 |
Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Embolization, Therapeutic; Endovascular Procedures; Humans; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2018 |
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Topics: Acute Disease; Aged; Aspirin; Brain Ischemia; Clopidogrel; Denmark; Dipyridamole; Drug Therapy, Combination; Female; Georgia; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; New Zealand; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Research Design; Risk Assessment; Stroke; Thrombolytic Therapy; Ticlopidine; Treatment Outcome; United Kingdom | 2018 |
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Ticlopidine | 2018 |
Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Heterozygote; Humans; Incidence; Male; Neurodegenerative Diseases; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Stroke; Ticlopidine | 2018 |
Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I).
Topics: Adult; Aged; Brain Ischemia; Clopidogrel; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke | 2019 |
Effect of dual versus mono antiplatelet therapy on recurrent stroke modulated by activated partial thromboplastin time.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Recurrence; Stroke | 2019 |
Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke.
Topics: Aged; Asian People; Brain Ischemia; Chronic Disease; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Stroke | 2019 |
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hematuria; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Secondary Prevention; Severity of Illness Index; Stroke | 2019 |
The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Disease-Free Survival; Female; Humans; Male; Myocardial Infarction; Registries; Risk Factors; Stroke; Survival Rate; Ticagrelor | 2019 |
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Constriction, Pathologic; Dual Anti-Platelet Therapy; Female; Humans; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Treatment Outcome | 2019 |
Ticlopidine with Ginkgo Biloba extract: a feasible combination for patients with acute cerebral ischemia.
Topics: Acute Disease; Alleles; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Ginkgo biloba; Humans; Male; Middle Aged; Pilot Projects; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2013 |
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Topics: Aged; Angioplasty, Balloon; Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Carotid Artery Diseases; Carotid Stenosis; Clopidogrel; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Male; Platelet Aggregation Inhibitors; Pyrroles; Research Design; Stents; Ticlopidine; Treatment Outcome | 2013 |
Dual antiplatelet therapy clopidogrel with low-dose cilostazol intensifies platelet inhibition in patients with ischemic stroke.
Topics: Adenosine Diphosphate; Aged; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Cilostazol; Clopidogrel; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2Y12; Risk Factors; Tetrazoles; Ticlopidine | 2013 |
Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events).
Topics: Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Female; Humans; Male; Risk Factors; Single-Blind Method; Smoking; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aorta, Thoracic; Aortic Diseases; Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Embolism; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Prospective Studies; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome; Warfarin | 2014 |
Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.
Topics: Aged; Brain Ischemia; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Simvastatin; Substrate Specificity; Ticlopidine | 2014 |
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Coronary Disease; Cytochrome P-450 CYP2C19; Double-Blind Method; Elective Surgical Procedures; Female; Follow-Up Studies; Gene Frequency; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Postoperative Complications; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Stents; Thiophenes; Ticlopidine | 2014 |
Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Male; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Survival Rate; Taiwan; Ticlopidine; Treatment Outcome | 2014 |
Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Humans; Phosphodiesterase 3 Inhibitors; Platelet Aggregation Inhibitors; Recurrence; Research Design; Stroke; Tetrazoles; Ticlopidine | 2015 |
Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Double-Blind Method; Female; Humans; International Cooperation; Male; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2015 |
Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
Topics: Brain Ischemia; Cerebral Hemorrhage; Chemoprevention; Clopidogrel; Cytochrome P-450 CYP2C19; Follow-Up Studies; Genotype; Humans; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Recurrence; Salicylates; Secondary Prevention; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome | 2016 |
Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
Topics: Aged; Aspirin; Atherosclerosis; Brain; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Thrombosis; Ticlopidine | 2016 |
The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
Topics: Aspirin; Brain Ischemia; Carotid Stenosis; Cerebral Arterial Diseases; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome | 2016 |
Abnormal glucose regulation increases stroke risk in minor ischemic stroke or TIA.
Topics: Aged; Aspirin; Blood Glucose; Brain Ischemia; Clopidogrel; Diabetes Complications; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Ticlopidine; Treatment Outcome | 2016 |
Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Stroke; Ticlopidine | 2018 |
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Ticlopidine; Treatment Outcome | 2017 |
Association of multiple infarctions and ICAS with outcomes of minor stroke and TIA.
Topics: Aged; Aspirin; Brain; Brain Infarction; Brain Ischemia; Clopidogrel; Female; Humans; Image Processing, Computer-Assisted; Intracranial Arteriosclerosis; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Treatment Outcome | 2017 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases | 2008 |
Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Stroke; Ticlopidine | 2008 |
Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intracranial Thrombosis; Male; Middle Aged; Naphthalenes; Platelet Aggregation; Platelet Aggregation Inhibitors; Propionates; Receptors, Thromboxane; Stroke; Ticlopidine | 2009 |
Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2010 |
Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vas
Topics: Angioplasty, Balloon, Coronary; Aspirin; Brain Ischemia; Cilostazol; Clinical Protocols; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Republic of Korea; Research Design; Stroke; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Sample Size; Ticlopidine; Treatment Outcome | 2011 |
Non-invasive alternating current stimulation induces recovery from stroke.
Topics: Aged; Aphasia; Aspirin; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Electric Stimulation Therapy; Electroencephalography; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Severity of Illness Index; Stroke; Stroke Rehabilitation; Ticlopidine; Treatment Outcome | 2010 |
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON is
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Tetrazoles; Ticlopidine; Treatment Outcome | 2011 |
Inhibitory interaction between calcium channel blocker and clopidogrel. -Efficacy of cilostazol to overcome it-.
Topics: Aged; Brain Ischemia; Calcium Channel Blockers; Cilostazol; Clopidogrel; Death; Drug Antagonism; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Tetrazoles; Ticlopidine | 2011 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Cerebral Infarction; Clopidogrel; Dipyridamole; Female; Humans; Intracranial Embolism; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Socioeconomic Factors; Stroke; Telmisartan; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents | 2012 |
Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
Topics: Age Factors; Aged; Aspirin; Body Weight; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Hypertension; Injections, Intravenous; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Registries; Risk Factors; Stroke; Ticlopidine; Tissue Plasminogen Activator | 2012 |
Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention.
Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticlopidine | 2012 |
Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Purinergic P2Y Receptor Antagonists; Risk Factors; Stroke; Ticagrelor; Ticlopidine | 2012 |
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Risk Assessment; Severity of Illness Index; Stroke; Thromboembolism; Ticlopidine | 2013 |
What is better antiplatelet agent to prevent recurrent stroke?
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Dipyridamole; Double-Blind Method; Evidence-Based Medicine; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome | 2012 |
Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Topics: Antigens, CD; Aspirin; Blood Platelets; Brain Ischemia; Case-Control Studies; Clopidogrel; Cross-Over Studies; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Secondary Prevention; Stroke; Tetraspanin 30; Ticlopidine | 2003 |
Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.
Topics: Aged; Arteriosclerosis; Aspirin; Blood Platelets; Brain Ischemia; C-Reactive Protein; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2002 |
Leukocyte count as an independent predictor of recurrent ischemic events.
Topics: Aspirin; Biomarkers; Brain Ischemia; Cause of Death; Clopidogrel; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Risk Factors; Stroke; Ticlopidine | 2004 |
Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
Topics: Adenosine Diphosphate; Adult; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Collagen; Epinephrine; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Ticlopidine | 2004 |
[The results of the MATCH study evidence for advantages of Clopidogrel monotherapy as secondary prophylaxis in cerebrovascular pathology].
Topics: Aged; Brain Ischemia; Clopidogrel; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Safety; Ticlopidine; Treatment Outcome | 2004 |
Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke.
Topics: Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; Case-Control Studies; Cell Adhesion; Clopidogrel; Cross-Over Studies; Dipyridamole; Drug Therapy, Combination; Female; Humans; Leukocytes; Male; Middle Aged; Platelet Aggregation; Stroke; Ticlopidine | 2005 |
Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.
Topics: Aged; Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine; Time Factors; Tomography, X-Ray Computed | 2005 |
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Female; Humans; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Risk Factors; Ticlopidine | 2005 |
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Topics: Adult; Arteriosclerosis; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; C-Reactive Protein; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Count; Platelet-Derived Growth Factor; Solubility; Stroke; Ticlopidine; Treatment Outcome; von Willebrand Factor | 2006 |
Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Thromboxane B2; Ticlopidine | 2008 |
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Topics: Adult; Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Myocardial Ischemia; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 1996 |
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigators.
Topics: Aspirin; Brain Ischemia; Cause of Death; Clopidogrel; Confidence Intervals; Double-Blind Method; Female; Hemorrhage; Hospitalization; Humans; Incidence; Ischemia; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Probability; Prognosis; Proportional Hazards Models; Risk Assessment; Secondary Prevention; Survival Analysis; Ticlopidine | 2000 |
171 other study(ies) available for clopidogrel and Brain Ischemia
Article | Year |
---|---|
Dual Antiplatelet Therapy Plus Argatroban Prevents Early Neurological Deterioration in Branch Atherosclerosis Disease.
Topics: Arginine; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke; Sulfonamides; Ticlopidine | 2022 |
Analysis of
Topics: Adult; Aged; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Retrospective Studies; Stroke; Treatment Outcome; United Kingdom | 2021 |
Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia.
Topics: Alleles; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2022 |
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrel.
Topics: Acute Coronary Syndrome; Brain Ischemia; China; Clopidogrel; Hemorrhage; Hemorrhagic Stroke; Humans; Intracranial Hemorrhages; Ischemic Stroke; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Stroke; Ticagrelor | 2022 |
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Mannitol; Nervous System Diseases; Piracetam; Pyrazoles; Pyridones; Retrospective Studies; SARS-CoV-2 | 2022 |
Use of dual antiplatelet therapy following posterior ischemic stroke.
Topics: Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Stroke | 2022 |
Comparative effectiveness of clopidogrel versus aspirin as a maintenance monotherapy 1 year after coronary artery bypass grafting.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2023 |
Safety and Efficacy of Baseline Antiplatelet Treatment in Patients Undergoing Mechanical Thrombectomy for Ischemic Stroke: Antiplatelets Before Mechanical Thrombectomy.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Intracranial Hemorrhages; Ischemic Stroke; Mechanical Thrombolysis; Stroke; Thrombectomy; Thrombolytic Therapy; Treatment Outcome | 2023 |
Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia-Reperfusion Injury in Rats.
Topics: Animals; Brain Ischemia; Clopidogrel; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Nanoparticles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Serum Albumin, Human | 2023 |
Review: After stroke or TIA, adding clopidogrel to aspirin for ≤ 1 month reduces recurrence and MACE.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Recurrence; Stroke | 2019 |
Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study.
Topics: Aged; Aspirin; Brain Ischemia; Cardiovascular Diseases; Cerebral Hemorrhage; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Male; Propensity Score; Retrospective Studies; Stroke | 2019 |
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients.
Topics: Aged; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Decision Support Techniques; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Predictive Value of Tests; Risk Assessment; Risk Factors; Stents; Stroke; Treatment Outcome | 2020 |
Intensive antiplatelet therapy with three agents does not reduce risk of another stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Stroke | 2020 |
Pharmacokinetics and pharmacodynamics analysis of XQ-1H and its combination therapy with clopidogrel on cerebral ischemic reperfusion injury in rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Ischemia; Chromatography, High Pressure Liquid; Clopidogrel; Drug Synergism; Ginkgolides; Humans; Infarction, Middle Cerebral Artery; Lactones; Male; Microsomes, Liver; Proto-Oncogene Proteins c-bcl-2; Rats; Reperfusion Injury; Tandem Mass Spectrometry | 2020 |
Dual Antiplatelet Therapy after Intravenous Thrombolysis for Acute Minor Ischemic Stroke.
Topics: Administration, Intravenous; Aged; Aspirin; Brain Ischemia; Clopidogrel; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Aspirin plus clopidogrel versus aspirin Mono-Therapy for ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2020 |
The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Stroke | 2020 |
Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Death; Drug Therapy, Combination; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Stroke | 2020 |
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel.
Topics: Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Epistasis, Genetic; Genotype; Humans; Integrin beta3; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, Purinergic P2Y12; Recurrence; Stroke | 2020 |
Association between CYP2C9 polymorphisms and ischemic stroke following endovascular neurointervention.
Topics: Aged; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; Cytochrome P-450 CYP2C9; Endovascular Procedures; Female; Humans; Male; Middle Aged; Pharmacogenomic Variants; Pilot Projects; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prospective Studies; Protective Factors; Queensland; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Victoria | 2020 |
Preventive Effects of Neuroprotective Agents in a Neonatal Rat of Photothrombotic Stroke Model.
Topics: Animals; Animals, Newborn; Aspirin; Brain Ischemia; Clopidogrel; Disease Models, Animal; Inflammation; Neuroprotective Agents; Rats; Rose Bengal; Stroke; Ubiquinone | 2020 |
Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study.
Topics: Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Multicenter Studies as Topic; Observational Studies as Topic; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome | 2020 |
Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations.
Topics: Aged; Asian People; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Cytochrome P-450 CYP2C19; Genotype; Humans; Ischemic Stroke; Loss of Function Mutation; Middle Aged; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Ticagrelor | 2020 |
Remote platelet function testing using P-selectin expression in patients with recent cerebral ischaemia on clopidogrel.
Topics: Aged; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Humans; Ischemic Stroke; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors | 2021 |
Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Pneumonia; Retrospective Studies; Stroke; Treatment Outcome | 2021 |
Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports.
Topics: Aged; Brain Ischemia; Cilostazol; Clopidogrel; Constriction, Pathologic; Drug Therapy, Combination; Gout; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vertebral Artery | 2020 |
Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke/TIA.
Topics: Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Ischemic Stroke; Platelet Aggregation Inhibitors; Prediabetic State; Stroke; Treatment Outcome | 2021 |
Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Propensity Score; Recurrence; Secondary Prevention; Stroke; Taiwan; Ticlopidine | 2020 |
Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-κB/NLRP3 Pathway in Ischemic Stroke.
Topics: Animals; Aspirin; Brain Ischemia; Clopidogrel; Inflammasomes; Ischemic Stroke; Isoindoles; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylbutyrates; Pyroptosis; Rats; Reperfusion Injury; Stroke; Ticagrelor | 2021 |
Non-persistence with anti-platelet therapy and long-term mortality after ischemic stroke: A nationwide study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Female; Humans; Ischemic Stroke; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Republic of Korea; Risk Assessment; Risk Factors; Stroke | 2021 |
Association of measured platelet reactivity with changes in P2Y
Topics: Aged; Blood Platelets; Brain Ischemia; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticlopidine | 2017 |
Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Cross-Sectional Studies; Cytochrome P-450 CYP2C19; Drug Resistance; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pharmacogenetics; Pharmacogenomic Testing; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Predictive Value of Tests; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2017 |
High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Recurrence; Risk Factors; Stroke; Thrombelastography; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Diabetes Mellitus, Type 2; Female; Greece; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Discharge; Platelet Aggregation Inhibitors; Proportional Hazards Models; Protective Factors; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Effects With and Without Clopidogrel Loading Treatment for Acute Ischemic Cerebrovascular Disease Patients: A Retrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Brain; Brain Ischemia; Clinical Decision-Making; Clopidogrel; Disease Progression; Female; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nerve Degeneration; Neuroprotective Agents; Odds Ratio; Patient Selection; Platelet Aggregation Inhibitors; Propensity Score; Retrospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Emergent loading dose of antiplatelets for stenting after IV rt-PA in acute ischemic stroke: a feasibility study.
Topics: Administration, Intravenous; Aged; Aspirin; Brain Ischemia; Clopidogrel; Computed Tomography Angiography; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Severity of Illness Index; Stents; Stroke; Ticlopidine; Tissue Plasminogen Activator; Tomography Scanners, X-Ray Computed; Treatment Outcome | 2018 |
[Influence of CYP2C19 gene polymorphisms on the efficacy of clopidogrel treatment for the prevention of ischemic stroke following coronary stent implantation].
Topics: Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stents; Stroke; Ticlopidine | 2017 |
STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Nomograms; Risk Factors; Stroke; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator | 2018 |
Pre-admission use of platelet inhibitors and short-term stroke mortality: a population-based cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Admission; Platelet Aggregation Inhibitors; Prognosis; Protective Factors; Registries; Risk Factors; Stroke; Subarachnoid Hemorrhage; Time Factors | 2018 |
Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Clopidogrel; Drug Interactions; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Medicaid; Middle Aged; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Ticlopidine; United States; Young Adult | 2018 |
Management of acute tandem occlusions: Stent-retriever thrombectomy with emergency stenting or angioplasty.
Topics: Aged; Angioplasty; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Carotid Artery Diseases; Clopidogrel; Female; Hematologic Agents; Humans; Male; Middle Aged; Prospective Studies; Prosthesis Implantation; Retrospective Studies; Stents; Stroke; Thrombectomy; Tissue Plasminogen Activator; Treatment Outcome | 2018 |
Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; China; Clinical Decision-Making; Clopidogrel; Cytochrome P-450 CYP2C19; Disease Progression; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Precision Medicine; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome | 2018 |
Clinical Significance of Acute and Serial Platelet Function Testing in Acute Ischemic Stroke.
Topics: Acute Disease; Aged; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prognosis; Prospective Studies; Ticlopidine | 2018 |
Positive trials in ischaemic stroke reported at ESOC 2018.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Stroke | 2018 |
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study.
Topics: Aged; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; United States | 2018 |
Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Secondary Prevention; Stroke; Treatment Outcome | 2018 |
The safety of triple antiplatelet therapy under thromboelastography guidance in patients undergoing stenting for ischemic cerebrovascular disease.
Topics: Aged; Aspirin; Brain Ischemia; Cilostazol; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Stroke; Thrombelastography; Ticlopidine | 2019 |
Clopidogrel may decrease the risk of post-stroke infection after ischaemic stroke.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Infection Control; Infections; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stroke | 2019 |
Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Topics: Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Drug Substitution; Female; Humans; Male; Middle Aged; Moyamoya Disease; Multivariate Analysis; Oxygen Radioisotopes; Perfusion Imaging; Platelet Aggregation Inhibitors; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2018 |
Thromboembolic Events with Enterprise Versus Pipeline: Porcine In Vivo Experiment.
Topics: Angiography, Digital Subtraction; Animals; Brain Ischemia; Carotid Artery, Common; Clopidogrel; Disease Models, Animal; Embolization, Therapeutic; Feasibility Studies; Graft Occlusion, Vascular; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Failure; Stents; Sus scrofa; Swine; Thromboembolism | 2019 |
Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Subarachnoid Hemorrhage; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recurrence; Secondary Prevention; Stroke; Time Factors | 2018 |
CT perfusion hypervolemia: brain ischemia or stroke mimic?
Topics: Aged; Angiography, Digital Subtraction; Brain Ischemia; Cerebral Angiography; Cerebrovascular Circulation; Clopidogrel; Computed Tomography Angiography; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Magnetic Resonance Angiography; Platelet Aggregation Inhibitors; Simvastatin; Stroke; Water-Electrolyte Imbalance | 2019 |
Prasugrel or clopidogrel for long-term secondary stroke prevention?
Topics: Brain Ischemia; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke; Ticlopidine | 2019 |
Platelet Surface CD62p and Serum Vitamin D Levels are Associated with Clopidogrel Resistance in Chinese Patients with Ischemic Stroke.
Topics: Aged; Asian People; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; China; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Prevalence; Risk Factors; Stroke; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2019 |
Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction.
Topics: Aged; Brain Ischemia; Clopidogrel; Comorbidity; Humans; Incidence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Risk Factors; Stroke; Sweden; Ticagrelor; Time Factors; Treatment Outcome | 2019 |
Recurrent Acute Ischemic Stroke Associated with Dolichoectatic Aneurysm of the Internal Carotid Artery.
Topics: Aged, 80 and over; Aneurysm; Anticoagulants; Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Internal; Clopidogrel; Humans; Male; Platelet Aggregation Inhibitors; Pyridines; Recurrence; Stroke; Thiazoles; Vertebrobasilar Insufficiency | 2019 |
Dual Versus Mono Antiplatelet Therapy in Large Atherosclerotic Stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Dual Anti-Platelet Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Stroke | 2019 |
Guideline: Starting dual antiplatelet therapy ≤ 24 h after high-risk TIA or minor ischemic stroke is recommended.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke | 2019 |
[Genetic and non-genetic factors of laboratory resistance to clopidogrel in patients with ischemic stroke].
Topics: Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Clopidogrel; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2019 |
Strong Recommendations Are Inappropriate in Person-Centred Care: The Case of Anti-Platelet Therapy.
Topics: Brain Ischemia; Clopidogrel; Humans; Ischemic Attack, Transient; Patient-Centered Care; Platelet Aggregation Inhibitors; Stroke | 2019 |
Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2013 |
Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Carotid Stenosis; Cerebral Revascularization; Clopidogrel; Drug Monitoring; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Receptors, Purinergic P2Y12; Registries; Retrospective Studies; Stents; Stroke; Ticlopidine; Treatment Outcome | 2014 |
Multiple electrode aggregometry in antiplatelet-related intracerebral haemorrhage.
Topics: Adult; Aspirin; Blood Platelets; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2013 |
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Ischemia; China; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Resistance; Drug-Eluting Stents; Female; Genotype; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Receptors, Purinergic P2Y12; Risk Factors; ROC Curve; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Isolated foot drop in acute infarction of the supplementary motor area.
Topics: Brain Ischemia; Cerebral Angiography; Cerebral Infarction; Clopidogrel; Diffusion Magnetic Resonance Imaging; Female; Foot; Humans; Hyperlipidemias; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Motor Cortex; Neural Conduction; Neurologic Examination; Neuromuscular Diseases; Oxygen; Platelet Aggregation Inhibitors; Ticlopidine; Tomography, X-Ray Computed; Vertigo | 2013 |
Microglial P2Y12 deficiency/inhibition protects against brain ischemia.
Topics: Animals; Apoptosis; Astrocytes; Brain Ischemia; CA1 Region, Hippocampal; Cell Hypoxia; Cell Movement; Cell Survival; Cells, Cultured; Clopidogrel; Coculture Techniques; Gene Knockdown Techniques; Glucose; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurons; NF-kappa B; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine | 2013 |
Factors influencing multiplate whole blood impedance platelet aggregometry measurements, during aspirin treatment in acute ischemic stroke: a pilot study.
Topics: Adult; Aged; Aspirin; Blood Platelets; Brain Ischemia; C-Reactive Protein; Cholesterol, HDL; Clopidogrel; Electric Impedance; Female; Fibrinogen; Glycated Hemoglobin; Humans; Leukocyte Count; Leukocytes; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Thromboxane B2; Ticlopidine; von Willebrand Factor | 2013 |
Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Topics: Aged; Angioplasty; Aspirin; Brain Ischemia; Carotid Stenosis; Cilostazol; Clopidogrel; Diffusion Magnetic Resonance Imaging; Drug Resistance; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Stents; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome | 2014 |
[Combined correction of impairments of the functional state of the haemostasis system in patients with ischaemic stroke].
Topics: Adult; Aged; Anticoagulants; Brain Ischemia; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hemostasis; Heparin; Humans; Male; Middle Aged; Motor Activity; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2013 |
Switching from aspirin to clopidogrel in patients with aspirin resistance after an ischemic stroke. Is it a good solution?
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Drug Resistance; Drug Substitution; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2014 |
Response to clopidogrel and its association with chronic kidney disease in noncardiogenic ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Stroke; Ticlopidine; Treatment Outcome | 2014 |
Safety evaluation of substituting clopidogrel for ticlopidine in Japanese patients with ischemic stroke--Hiroshima ticlopidine, clopidogrel safe exchange trial.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Drug Substitution; Female; Fibrinolytic Agents; Hemorrhage; Humans; Japan; Male; Middle Aged; Prospective Studies; Stroke; Ticlopidine; Treatment Outcome | 2014 |
Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Renal Dialysis; Retrospective Studies; Stroke; Ticlopidine; Treatment Outcome | 2014 |
The roles and issues of P2Y12 percent inhibition assessed by VerifyNow assay for patients undergoing Neurointervention: a prospective study.
Topics: Aged; Brain Ischemia; Clopidogrel; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome | 2014 |
VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cell Adhesion Molecules; China; Clopidogrel; Drug Resistance; Female; Genetic Markers; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Stroke; Ticlopidine; Treatment Failure; Young Adult | 2014 |
Influence of CYP2C19 polymorphisms on platelet reactivity and clinical outcomes in ischemic stroke patients treated with clopidogrel.
Topics: Aged; Blood Platelets; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prognosis; Stroke; Ticlopidine; Treatment Outcome | 2015 |
CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel.
Topics: Aged; Asian People; Brain; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Diffusion Magnetic Resonance Imaging; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2015 |
Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Data Interpretation, Statistical; Drug Therapy, Combination; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proportional Hazards Models; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Risk; Stroke; Ticlopidine | 2015 |
Predictive value of high residual platelet reactivity by flow cytometry for outcomes of ischemic stroke patients on clopidogrel therapy.
Topics: Aged; Aged, 80 and over; Blood Platelets; Brain Ischemia; Clopidogrel; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine | 2015 |
ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients.
Topics: Adenosine Diphosphate; Adolescent; Adult; Aged; Asian People; ATP Binding Cassette Transporter, Subfamily B; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; DNA Methylation; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Promoter Regions, Genetic; Stroke; Ticlopidine; Young Adult | 2015 |
Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms.
Topics: Adult; Aged; Brain Ischemia; Clopidogrel; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome | 2016 |
Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
Topics: Aged; Biomarkers, Pharmacological; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Humans; Male; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Prospective Studies; Random Allocation; Stroke; Ticlopidine; Treatment Outcome | 2015 |
Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate.
Topics: Aged; Brain Ischemia; Clopidogrel; Drug Resistance; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Statistics as Topic; Stents; Ticlopidine | 2015 |
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy.
Topics: Adult; Aged; Alleles; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; Cytochrome P-450 CYP2C19; Embolization, Therapeutic; Endovascular Procedures; Female; Genetic Predisposition to Disease; Genotype; Humans; Longitudinal Studies; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Stents; Ticlopidine | 2016 |
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin | 2015 |
Comparison of VerifyNow P2Y12 and thrombelastography for assessing clopidogrel response in stroke patients in China.
Topics: Adenosine Diphosphate; Aged; Brain Ischemia; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Stroke; Thrombelastography; Ticlopidine | 2016 |
Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Denmark; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Recurrence; Registries; Secondary Prevention; Stroke; Ticlopidine | 2015 |
Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Biomarkers; Brain Ischemia; CD40 Ligand; Clopidogrel; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; P-Selectin; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2016 |
[Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
Topics: Aged; Alleles; Asian People; Brain Ischemia; China; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Recurrence; Risk Factors; Sequence Analysis, DNA; Stroke; Ticlopidine; Time Factors | 2015 |
Effect of atorvastatin co-treatment on inhibition of platelet activation by clopidogrel in patients with ischemic stroke.
Topics: Aged; Atorvastatin; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Platelet Activation; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2015 |
Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Disability Evaluation; Female; Hospital Mortality; Humans; Logistic Models; Male; Odds Ratio; Patient Admission; Patient Discharge; Platelet Aggregation Inhibitors; Prospective Studies; Protective Factors; Recovery of Function; Risk Factors; Severity of Illness Index; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessment.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Incidence; Male; Medication Adherence; Middle Aged; Recurrence; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome; Warfarin; Young Adult | 2016 |
Association between high on-treatment platelet reactivity and occurrence of cerebral ischemic events in patients undergoing percutaneous coronary intervention.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Risk Factors; Ticlopidine | 2016 |
Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.
Topics: Acute Coronary Syndrome; Aged; Brain Ischemia; Clopidogrel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; CpG Islands; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Recurrence; Stroke; Ticlopidine; TNF Receptor-Associated Factor 3 | 2016 |
Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia.
Topics: Aged; Alleles; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prognosis; Stents; Stroke; Ticlopidine; Treatment Outcome | 2016 |
Extended use of clopidogrel and aspirin after ischemic stroke.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Post-Exposure Prophylaxis; Stroke; Ticlopidine | 2016 |
Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.
Topics: Aged; Aged, 80 and over; Asian People; Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Male; Middle Aged; Nervous System Diseases; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome | 2016 |
High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
Topics: Acute Disease; Adenosine; Aspirin; Blood Platelets; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Survival Analysis; Ticagrelor; Ticlopidine | 2016 |
Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
Topics: Aged; Aged, 80 and over; Brain Ischemia; China; Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Disability Evaluation; Drug Interactions; Drug Resistance; Female; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Pharmacogenomic Testing; Pharmacogenomic Variants; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Single Nucleotide; Polypharmacy; Prospective Studies; Proton Pump Inhibitors; Recurrence; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with clopidogrel.
Topics: Aged; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Pharmacogenetics; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Proportional Hazards Models; Retrospective Studies; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Reply to effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with Clopidogrel.
Topics: Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2017 |
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention.
Topics: Adenosine Monophosphate; Aged; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Clopidogrel and ischemic stroke outcomes by smoking status: Smoker's paradox?
Topics: Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Smoking; Stroke; Ticlopidine; Treatment Outcome | 2017 |
Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.
Topics: Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Propensity Score; Renal Dialysis; Retrospective Studies; Stroke; Survival Rate; Taiwan; Ticlopidine | 2017 |
Association of genetic variant and platelet function in patients undergoing neuroendovascular stenting.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Aspirin; Brain Ischemia; Clopidogrel; Female; Genetic Variation; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Recurrence; Stents; Stroke; Thrombelastography; Ticlopidine | 2017 |
Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Topics: Adult; Aged; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Prescriptions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Health Care Surveys; Humans; Hungary; Male; Middle Aged; Neurology; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Stroke; Surveys and Questionnaires; Ticlopidine | 2008 |
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator | 2008 |
ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Aspirin; Brain Ischemia; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2008 |
Facts and controversies of aspirin and clopidogrel therapy.
Topics: Acute Coronary Syndrome; Aspirin; Atherosclerosis; Blood Platelets; Brain Ischemia; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Thiophenes; Ticlopidine | 2009 |
Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recombinant Proteins; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombolytic Therapy; Thrombophilia; Ticlopidine; Tissue Plasminogen Activator | 2009 |
Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Brain Ischemia; Cerebral Arteries; Clopidogrel; Female; Fibrinolytic Agents; Heparin; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Retrospective Studies; Stents; Stroke; Thrombectomy; Ticlopidine; Treatment Outcome; Vascular Surgical Procedures | 2009 |
Medical treatment of patients with intracranial atherosclerotic disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Embolism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Arteriosclerosis; Intracranial Thrombosis; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles; Ticlopidine | 2009 |
Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats.
Topics: Animals; Aspirin; Brain Ischemia; Cells, Cultured; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Endothelial Cells; Epoprostenol; Humans; Hypertension; Laser-Doppler Flowmetry; Male; Nitric Oxide; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Tetrazoles; Ticlopidine | 2010 |
Association of platelet responsiveness with clopidogrel metabolism: role of compliance in the assessment of "resistance".
Topics: Aged; Blood Platelets; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Ticlopidine | 2009 |
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Thromboembolism; Thrombosis; Ticlopidine; Warfarin | 2009 |
Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Contraindications; Dipyridamole; Drug Incompatibility; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Ticlopidine; Tissue Plasminogen Activator; Treatment Outcome; Young Adult | 2010 |
[Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Embolism; Exercise Test; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin | 2010 |
Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Stroke; Survivors; Ticlopidine; Treatment Outcome; Young Adult | 2010 |
Lateral medullary ischemia presenting with persistent hiccups and vertigo.
Topics: Administration, Oral; Aged; Angiography; Anticoagulants; Brain Ischemia; Clopidogrel; Head Movements; Heparin; Hiccup; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Medulla Oblongata; Nystagmus, Pathologic; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome; Vertigo | 2010 |
Early stent thrombosis with progressive brainstem infarction in a clopidogrel non-responder.
Topics: Aged; Brain Infarction; Brain Ischemia; Clopidogrel; Disease Progression; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine | 2010 |
Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the management of atherothrombosis with clopidogrel in high-risk patients (MATCH) clinical trial results.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prescriptions; Stroke; Ticlopidine; United States | 2010 |
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Proportional Hazards Models; Registries; Risk; Stroke; Ticlopidine; Warfarin | 2010 |
An endovascular canine middle cerebral artery occlusion model for the study of leptomeningeal collateral recruitment.
Topics: Angiography; Animals; Anticoagulants; Brain Ischemia; Carotid Arteries; Clopidogrel; Disease Models, Animal; Dogs; Feasibility Studies; Heparin; Infarction, Middle Cerebral Artery; Middle Cerebral Artery; Multivariate Analysis; Platelet Aggregation Inhibitors; Statistics as Topic; Ticlopidine | 2011 |
Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levels.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Down-Regulation; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Evaluation of clopidogrel resistance in ischemic stroke patients.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Brain Ischemia; Clopidogrel; Drug Resistance; Female; Humans; In Vitro Techniques; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Stroke; Ticlopidine | 2011 |
What is the best first agent to give to a patient with acute ischaemic stroke? Aspirin, heparin, clopidogrel, cilostazol or dipyridamole?
Topics: Aspirin; Brain Ischemia; Cilostazol; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine | 2010 |
Fluoxetine and motor recovery after ischaemic stroke.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Resistance; Fluoxetine; Humans; Motor Skills; Platelet Aggregation Inhibitors; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Stroke; Stroke Rehabilitation; Ticlopidine; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
Fluoxetine and motor recovery after ischaemic stroke.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Brain Ischemia; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Resistance; Fluoxetine; Humans; Motor Skills; Platelet Aggregation Inhibitors; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Stroke; Stroke Rehabilitation; Ticlopidine; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events.
Topics: Adult; Aged; Aspirin; Brain Ischemia; Clopidogrel; Female; Follow-Up Studies; Foramen Ovale, Patent; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Stroke; Ticlopidine; Treatment Outcome | 2011 |
Acetylsalicylic acid, but not clopidogrel, inhibits therapeutically induced cerebral arteriogenesis in the hypoperfused rat brain.
Topics: Animals; Aspirin; Brain Ischemia; Cell Line; Cerebral Angiography; Cerebrovascular Circulation; Chemotaxis, Leukocyte; Clopidogrel; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Monocytes; Neovascularization, Physiologic; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ticlopidine; Vasodilation | 2012 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Clopidogrel; Diastole; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Reference Values; Risk; Stroke; Systole; Telmisartan; Ticlopidine; Vascular Diseases | 2011 |
Dose-dependent effect of early antiplatelet therapy in acute ischaemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Body Mass Index; Brain Ischemia; Clopidogrel; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine | 2012 |
Clopidogrel responsiveness in stroke patients on a chronic aspirin regimen.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Equipment Design; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Predictive Value of Tests; Reproducibility of Results; Stroke; Thrombelastography; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Antiplatelet therapy for transient ischemic attack.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Clopidogrel; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Primary Prevention; Prognosis; Secondary Prevention; Stroke; Ticlopidine | 2012 |
[Perioperative management of antiplatelet therapy in thoracic surgery. A survey of German hospitals].
Topics: Arterial Occlusive Diseases; Aspirin; Attitude of Health Personnel; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Data Collection; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Germany; Humans; Myocardial Infarction; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Stents; Surveys and Questionnaires; Thoracic Surgical Procedures; Ticlopidine | 2012 |
Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Proportional Hazards Models; Secondary Prevention; Stroke; Survival Analysis; Ticlopidine; Treatment Outcome | 2012 |
Obesity and intracranial in-stent thrombosis.
Topics: Abciximab; Angioplasty, Balloon; Antibodies, Monoclonal; Aspirin; Body Mass Index; Brain Ischemia; Cerebral Angiography; Clopidogrel; Endovascular Procedures; Humans; Immunoglobulin Fab Fragments; Intracranial Thrombosis; Male; Middle Aged; Obesity, Morbid; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Ticlopidine | 2013 |
Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Stroke; Subarachnoid Hemorrhage; Ticlopidine | 2012 |
Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Brain Ischemia; Clopidogrel; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stroke; Ticlopidine | 2013 |
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin | 2012 |
Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study.
Topics: Antigens, CD; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; Clopidogrel; Cross-Over Studies; Humans; P-Selectin; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 30; Ticlopidine | 2003 |
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
Topics: Aged; Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Databases, Factual; Female; Hospitalization; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Secondary Prevention; Stroke; Survival Rate; Ticlopidine; Treatment Outcome | 2004 |
Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Antigens, CD; Aspirin; Blood Platelets; Brain Ischemia; Clopidogrel; Collagen; Female; Flow Cytometry; Heparin; Humans; Intracranial Arteriosclerosis; Lipids; Male; Middle Aged; P-Selectin; Patient Selection; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Stroke; Tetraspanin 30; Ticlopidine; Time Factors | 2004 |
[Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
Topics: Adult; Aged; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Arteries; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Eptifibatide; Female; Heparin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stroke; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler | 2004 |
There is no evidence that the benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
Topics: Arteriosclerosis; Aspirin; Brain Ischemia; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Prognosis; Risk; Ticlopidine | 2004 |
Creative cost-effectiveness analysis of CAPRIE data- dust in our eyes.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Drug Costs; Humans; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Stroke; Ticlopidine | 2005 |
Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease.
Topics: Aged; Alleles; Aspirin; Brain Ischemia; Cerebrovascular Circulation; Clopidogrel; Cohort Studies; Exons; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heterozygote; Humans; Ischemia; Membrane Proteins; Middle Aged; Mutation; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Genetic; Prevalence; Proportional Hazards Models; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2005 |
Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats.
Topics: Animals; Antioxidants; Antipyrine; Aspirin; bcl-2-Associated X Protein; Blotting, Western; Brain Edema; Brain Ischemia; Cerebral Infarction; Clopidogrel; Cyclic AMP Response Element-Binding Protein; Disability Evaluation; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Administration Routes; Edaravone; Functional Laterality; Gene Expression Regulation; Hypoxia, Brain; Male; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Ticlopidine; Tumor Suppressor Proteins | 2005 |
[The efficacy of surgical and conservative methods in secondary prevention of carotid ischemic stroke].
Topics: Aged; Brain; Brain Ischemia; Carotid Stenosis; Cerebral Arteries; Clopidogrel; Combined Modality Therapy; Endarterectomy, Carotid; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Surgical Flaps; Ticlopidine; Ultrasonography | 2005 |
[Prophylaxis of stroke].
Topics: Age Factors; Aged; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Brain Ischemia; Carotid Stenosis; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diet; Drug Therapy, Combination; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Life Style; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Smoking Cessation; Stents; Stroke; Ticlopidine; Time Factors | 2005 |
The risks and safety of clopidogrel in pediatric arterial ischemic stroke.
Topics: Adolescent; Aspirin; Brain Ischemia; Child; Child, Preschool; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Hand; Headache; Hematoma, Subdural; Humans; Hypesthesia; Infant; Infant, Newborn; Moyamoya Disease; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Ticlopidine; Tomography, X-Ray Computed | 2006 |
High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Hospitalization; Humans; New York; Platelet Aggregation Inhibitors; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Ticlopidine; Treatment Outcome | 2006 |
Enhanced platelet activation by prolactin in patients with ischemic stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Ischemic Attack, Transient; Leptin; Male; Middle Aged; P-Selectin; Platelet Activation; Prolactin; Retrospective Studies; Risk Factors; Stroke; Thrombophilia; Ticlopidine | 2006 |
Viscosity, hemostasis and inflammation in atherosclerotic heart diseases.
Topics: Aged; Aspirin; Blood Viscosity; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Glucose; Glycated Hemoglobin; Hemostasis; Humans; Inflammation; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; von Willebrand Factor | 2006 |
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Ischemia; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Female; Giant Cell Arteritis; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin | 2006 |
TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents.
Topics: Acute Disease; Adult; Aged; Aspirin; Brain Ischemia; Cells, Cultured; Clopidogrel; Dipyridamole; Female; Humans; In Vitro Techniques; Interleukin-8; Leukocytes; Male; Middle Aged; Piracetam; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tumor Necrosis Factor-alpha | 2007 |
Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance? : a study in older patients.
Topics: Adult; Aged; Alleles; Brain Ischemia; Clopidogrel; Drug Resistance; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Ticlopidine | 2007 |
Rate, degree, and predictors of recovery from disability following ischemic stroke.
Topics: Aged; Brain Ischemia; Causality; Clopidogrel; Cohort Studies; Diabetes Complications; Disability Evaluation; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prognosis; Prospective Studies; Recovery of Function; Regression Analysis; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2007 |
[Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Topics: Aspirin; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Recurrence; Stroke; Thromboembolism; Ticlopidine | 2007 |
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Ticlopidine | 2008 |
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations].
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Aspirin; Brain Infarction; Brain Ischemia; Clopidogrel; Diabetes Mellitus; Dipyridamole; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2008 |
[Antithrombotic therapy in operations on extracranial arteries].
Topics: Aged; Brain Ischemia; Clopidogrel; Combined Modality Therapy; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Postoperative Complications; Russia; Ticlopidine | 2008 |
CAPRIE trial.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine; Treatment Outcome | 1997 |
CAPRIE trial.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Ticlopidine; Treatment Outcome | 1997 |
CAPRIE trial.
Topics: Aspirin; Brain Ischemia; Clopidogrel; Drug Costs; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 1997 |
Clinical safety and efficacy of clopidogrel--implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic disease.
Topics: Arteriosclerosis; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; United States; Vascular Diseases | 1998 |
[Prevention of thrombosis after ischemic cerebrovascular attack--new possibilities].
Topics: Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Ticlopidine | 1998 |
Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemi
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Evidence-Based Medicine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk; Saskatchewan; Ticlopidine; Treatment Outcome | 1999 |
CURE--clopidogrel's major advance.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2001 |